CooperSurgical PGTai Technology Platform, ERPeak Endometrial Receptivity Test
CooperSurgical Fertility and Genomic Solutions has launched the CooperGenomics PGTai technology platform and the ERPeak endometrial receptivity test. Both will be available in North American from November 1 and internationally starting in January 2019.
The PGTai platform uses artificial intelligence and machine learning to improve the analysis, interpretation, and reporting of preimplantation genetic testing for aneuploidies (PGT-A). It is built on data from more than 1,000 biopsies that led to healthy babies. To validate the platform, the company analyzed sequencing data from more than 10,000 embryos and 5 million data points.
The ERPeak endometrial receptivity test detects the receptivity status of a woman's endometrium accurately and reliably. It measures the expression of several relevant hormone-regulated genes.